Recent News

• 01.12.2026 - Mereo BioPharma Provides Corporate Update
• 12.29.2025 - Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta
• 11.10.2025 - Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights
• 08.12.2025 - Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
• 08.12.2025 - Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Recent Filings

• 01.12.2026 - EX-99.1 EX-99.1
• 01.12.2026 - 8-K Current report
• 01.09.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.06.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 12.29.2025 - EX-99.1 EX-99.1
• 12.29.2025 - 8-K Current report
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.10.2025 - EX-99.1 EX-99.1
• 11.10.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]